We are live on ! Find out more
NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of NAVB yet.

NAVB Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Navidea Biopharmaceuticals Inc. (NAVB) for Q2 2024, worth a combined $0 — down 100% from $13 a quarter earlier.

Fund positioning in NAVB was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Navidea Biopharmaceuticals Inc. (NAVB) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $0 of Navidea Biopharmaceuticals Inc. stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Navidea Biopharmaceuticals Inc. positions in Q2 2024 and 0 closed out.

Based on aggregated 13F filings for Q2 2024.